Stay updated on Pembrolizumab & Enfortumab in Rare Kidney Cancers Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Enfortumab in Rare Kidney Cancers Clinical Trial page.

Latest updates to the Pembrolizumab & Enfortumab in Rare Kidney Cancers Clinical Trial page
- Check10 days agoChange DetectedAdded Revision: v3.5.2 and deleted Revision: v3.5.0. This reflects a minor version update on the page.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check39 days agoChange DetectedFooter revision updated from v3.4.3 to v3.5.0. This is a minor technical update reflecting the latest site version.SummaryDifference0.1%

- Check46 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3. This reflects a minor site update.SummaryDifference0.1%

- Check75 days agoChange DetectedRevision: v3.4.2 was added to the site, and the lapse funding notice along with the prior Revision: v3.4.1 reference were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check82 days agoChange DetectedA new funding/operating status notice was added, and the site revision was updated from v3.4.0 to v3.4.1.SummaryDifference1%

- Check89 days agoChange DetectedAdded Show glossary and No FEAR Act Data, removed No FEAR Act data, and updated the revision to v3.4.0 from v3.3.4.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab & Enfortumab in Rare Kidney Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Enfortumab in Rare Kidney Cancers Clinical Trial page.